Skip to main content

Table 1 Effect of STZ and obstruction for right kidney on fasting serum glucose and blood pressure

From: Management of cardiac fibrosis in diabetic rats; the role of peroxisome proliferator activated receptor gamma (PPAR-gamma) and calcium channel blockers (CCBs)

Groups

 

Control

Diabetic Control

Diabetic Hypertensive Control

Rosiglitazone

Rosiglitazone+Felodipine

Glucose (mg/dL)

98.00 ± 9.61

371.30 ± 39.09 ^

501.80 ± 54.44*

236.90 ± 47.98#

195.30 ± 47.35#

Blood Pressure (mmHg)

126.20 ± 4.78

158.40 ± 14.09^

195.50 ± 13.26*

189.90 ± 13.16

162.70 ± 16.73#a

  1. Values are expressed as mean ± SD. Number of rats per group n = 10.
  2. STZ, streptozotocin
  3. ^ Significant difference from normal control at P < 0.05.
  4. * Significant difference from diabetic control at P < 0.05.
  5. # Significant difference from diabetic hypertensive control at P < 0.05.
  6. a Means of treated groups with different superscript are significantly different from each other at P < 0.05.